|
Variable
|
Total No (%)
|
ALDH1 (+) No (%)
|
P-value
|
|---|
|
Total
|
119 (100)
|
56 (47)
| |
|
Age
| | |
0.100
|
|
>50
|
67 (56)
|
25 (37)
| |
|
≤50
|
52 (44)
|
31 (59)
|
|
T stage
| | | |
|
T1
|
22 (18)
|
9 (40)
| |
|
T2
|
78 (65)
|
38 (49)
| |
|
T3
|
19 (17)
|
8 (42)
|
0.985
|
|
Nodal status
| | | |
|
Positive
|
96 (81)
|
46 (50)
| |
|
Negative
|
23 (19)
|
8 (38)
|
0.455
|
|
Histological type
| | | |
|
IDC
|
108 (88.5)
|
52 (48)
| |
|
ILD
|
11 (11.5)
|
4 (36)
|
0.537
|
|
Pathological grade
| | | |
|
1 or 2
|
46 (39)
|
22 (48)
| |
|
3
|
73 (61)
|
34 (46)
|
0.395
|
|
Breast cancer subtype
| | | |
|
Luminal A
|
24 (20)
|
10 (41)
| |
|
Luminal B
|
49 (40)
|
20 (41)
| |
|
HER2
|
17 (14)
|
10 (59)
| |
|
TN
|
29 (24)
|
16 (55)
|
0.431
|
|
Ki67 (N = 106)
| | | |
|
>20%
|
68 (64)
|
29 (58)
| |
|
≤20%
|
38 (36)
|
21 (42)
|
0.311
|
|
Surgery
| | | |
|
Mastectomy
|
56 (47)
|
21 (37)
| |
|
BCS
|
63 (53)
|
35 (55)
|
0.066
|
|
Response
| | | |
|
pCR
|
26 (22)
|
6 (23)
| |
|
Non-pCR
|
93 (78)
|
50 (54)
|
0.007
|
- ALDH1, aldehyde dehydrogenase-1; pCR, pathologic complete response; HER2, human epidermal growth factor receptor 2; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; TN, triple negative.
